Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Chris Lange | Jan 30, 2017 at 11:45 AM EST

Top 7 Earnings Reports to Look For Tuesday

24/7 Wall St. has put together a preview of some of the major companies reporting on Tuesday, including Apple and…

Chris Lange | Jan 26, 2017 at 9:50 AM EST

Short Sellers Run for Cover From Major Pharma

The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | Jan 18, 2017 at 11:05 AM EST

Wednesday’s Top Biopharma Winners

Trump said last week that companies in the health care sector are “getting away with murder,” and that something had…

Trey Thoelcke | Jan 18, 2017 at 7:40 AM EST

What Eli Lilly Gets With CoLucid Acquisition

This acquisition not only will enhance Eli Lilly's existing portfolio in pain management for migraine, but it also adds a…

Jon C. Ogg | Jan 17, 2017 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: American Express, JPMorgan, Netflix, Nordstrom, Twitter and Many More

The top analyst upgrades, downgrades and initiations seen on Tuesday include American Express, JPMorgan, Netflix, Nordstrom and Twitter.

Chris Lange | Jan 12, 2017 at 10:50 AM EST

Major Pharma Short Interest Declines Ahead of Trump Comments

The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a…

Lee Jackson | Jan 11, 2017 at 9:35 AM EST

JPMorgan Makes Big Changes to US Analyst Focus List for January

These are five top new picks that the JPMorgan team likes this month. All make good sense for growth portfolios.

Chris Lange | Dec 28, 2016 at 10:25 AM EST

Short Interest Rises in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest increased in most of…

Lee Jackson | Dec 5, 2016 at 8:20 AM EST

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

These are stocks that make good sense for investors looking to add to their overall equity holdings. They are all…

Lee Jackson | Dec 2, 2016 at 10:05 AM EST

5 Dividend Retirement Stocks to Buy Now and Hold Forever

For those looking to generate income, equities remain one of the best resources, and these five look like long-term winners.

Lee Jackson | Dec 1, 2016 at 8:10 AM EST

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for…

Lee Jackson | Nov 29, 2016 at 8:25 AM EST

Merrill Lynch Makes Huge Changes by Removing 2 Blue Chips From US 1 List

In a recent research note, the analysts at Merrill Lynch make a big move by removing two blue chips from…

Chris Lange | Nov 26, 2016 at 10:00 AM EST

4 Companies That Destroyed Shareholders Last Week

This trading week has been shorter than most with Thanksgiving taking place on Thursday. As a result not too many…

Chris Lange | Nov 23, 2016 at 10:22 AM EST

Why Eli Lilly Won’t Forget This Alzheimer’s Failure Anytime Soon

Eli Lilly & Co. (NYSE: LLY) is watching its shares in free fall on Wednesday, not from any election or…

Lee Jackson | Nov 15, 2016 at 10:10 AM EST

4 Top Merrill Lynch Q4 Buy Ideas Look Cheap Now and Pay Dividends

Now is a good time to add quality stocks in front of what is usually a very good time of…

1 … 23 24 25 26 27 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Top 7 Earnings Reports to Look For Tuesday

Short Sellers Run for Cover From Major Pharma

Wednesday’s Top Biopharma Winners

What Eli Lilly Gets With CoLucid Acquisition

Top Analyst Upgrades and Downgrades: American Express, JPMorgan, Netflix, Nordstrom, Twitter and Many More

Major Pharma Short Interest Declines Ahead of Trump Comments

JPMorgan Makes Big Changes to US Analyst Focus List for January

Short Interest Rises in Major Pharma

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

5 Dividend Retirement Stocks to Buy Now and Hold Forever

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Merrill Lynch Makes Huge Changes by Removing 2 Blue Chips From US 1 List

4 Companies That Destroyed Shareholders Last Week

Why Eli Lilly Won’t Forget This Alzheimer’s Failure Anytime Soon

4 Top Merrill Lynch Q4 Buy Ideas Look Cheap Now and Pay Dividends

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Eli Lilly : LLY

All Eli Lilly Articles

Top 7 Earnings Reports to Look For Tuesday

Short Sellers Run for Cover From Major Pharma

Wednesday’s Top Biopharma Winners

What Eli Lilly Gets With CoLucid Acquisition

Top Analyst Upgrades and Downgrades: American Express, JPMorgan, Netflix, Nordstrom, Twitter and Many More

Major Pharma Short Interest Declines Ahead of Trump Comments

JPMorgan Makes Big Changes to US Analyst Focus List for January

Short Interest Rises in Major Pharma

4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

5 Dividend Retirement Stocks to Buy Now and Hold Forever

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Merrill Lynch Makes Huge Changes by Removing 2 Blue Chips From US 1 List

4 Companies That Destroyed Shareholders Last Week

Why Eli Lilly Won’t Forget This Alzheimer’s Failure Anytime Soon

4 Top Merrill Lynch Q4 Buy Ideas Look Cheap Now and Pay Dividends

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s